6 years ago
Allergan was blasted for its unusual Mohawk patent license, and now it's a total flop
After months of criticism that even spilled into a judge's opinion in a separate case, Allergan's Restasis patent deal with the Saint Regis Mohawk Tribe just didn't work. Thanks to a Friday ruling, the blockbuster eye drug has to face the very patent challenge Allergan sought to prevent.
Continue Reading
https://www.fiercepharma.com
Join the Discussion